Invion Limited
A$0.04-A$0.00 (-5.41%)
Invion Limited’s quoted price sits in the lower half of its reported 52-week range, 68.18% below the high.
OTC · HPMM · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Hemp Naturals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Hemp Naturals, Inc. operates as a burgeoning enterprise, focusing on the research, development, acquisition, and sale of products derived from industrial hemp. Its current offerings include rolling papers, which are distributed across 25 retail locations such as gas stations, convenience stores, tobacco shops, and liquor stores. The company plans to expand its product line to encompass a wider array of consumer goods utilizing industrial hemp and/or the non-psychoactive components of the cannabis plant. This future range is expected to feature items like nutritional hemp health supplements, hemp-based food products (including shakes), beauty supplies, and apparel crafted from hemp. Established in 2015, Hemp Naturals, Inc. maintains its headquarters in Sunny Isles Beach, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.04-A$0.00 (-5.41%)
Invion Limited’s quoted price sits in the lower half of its reported 52-week range, 68.18% below the high.
$0.00$0.00 (0.0%)
Rimrock Gold Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
$0.00$0.00 (0.0%)
CBD Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00$0.00 (0.0%)
Link Reservations Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Aequus Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.25% below the high.
$0.00$0.00 (0.0%)
Golden Developing Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Juva Life Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.17% below the high.
$0.00$0.00 (0.0%)
Medicine Man Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.55% below the high.